全文获取类型
收费全文 | 3562篇 |
免费 | 406篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 112篇 |
妇产科学 | 79篇 |
基础医学 | 182篇 |
口腔科学 | 10篇 |
临床医学 | 2069篇 |
内科学 | 238篇 |
皮肤病学 | 6篇 |
神经病学 | 155篇 |
特种医学 | 33篇 |
外科学 | 239篇 |
综合类 | 83篇 |
一般理论 | 1篇 |
预防医学 | 399篇 |
眼科学 | 16篇 |
药学 | 173篇 |
肿瘤学 | 175篇 |
出版年
2023年 | 31篇 |
2021年 | 25篇 |
2020年 | 28篇 |
2019年 | 34篇 |
2018年 | 106篇 |
2017年 | 98篇 |
2016年 | 91篇 |
2015年 | 114篇 |
2014年 | 129篇 |
2013年 | 153篇 |
2012年 | 97篇 |
2011年 | 85篇 |
2010年 | 96篇 |
2009年 | 116篇 |
2008年 | 90篇 |
2007年 | 106篇 |
2006年 | 88篇 |
2005年 | 79篇 |
2004年 | 96篇 |
2003年 | 90篇 |
2002年 | 76篇 |
2001年 | 116篇 |
2000年 | 70篇 |
1999年 | 154篇 |
1998年 | 170篇 |
1997年 | 175篇 |
1996年 | 226篇 |
1995年 | 178篇 |
1994年 | 175篇 |
1993年 | 118篇 |
1992年 | 112篇 |
1991年 | 102篇 |
1990年 | 90篇 |
1989年 | 64篇 |
1988年 | 62篇 |
1987年 | 37篇 |
1986年 | 27篇 |
1985年 | 35篇 |
1984年 | 13篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 14篇 |
1980年 | 9篇 |
1979年 | 14篇 |
1977年 | 11篇 |
1975年 | 14篇 |
1973年 | 13篇 |
1970年 | 10篇 |
1969年 | 13篇 |
1964年 | 8篇 |
排序方式: 共有3973条查询结果,搜索用时 296 毫秒
61.
M. R. Dobrinska D. E. Furst T. Spiegel W. C. Vincek R. Tompkins D. E. Duggan R. O. Davies H. E. Paulus 《Biopharmaceutics & drug disposition》1983,4(4):347-358
The biliary secretion of sulindac and metabolites after a single 400 mg oral dose of the drug was studied in 3 elective gallbladder surgical patients following placement of an occludable T-tube in the common bile duct. Bile and systemic plasma were sampled at frequent intervals for up to 36 h postdose. The apparent biliary clearance (V?cl,bilc) of the prodrug sulindac is about 25 times greater than that of the pharmacologically active sulfide metabolite. The total biliary flux of drug in normal man with an uninterrupted enterohepatic cycle, calculated from V?cl,bile and historic mean plasma drug AUC values, averages 144 and 12·2 per cent of the dose as sulindac and the sulfide metabolite, respectively. Thus, enterohepatic recycling of the drug in man is principally in the form of the prodrug which not only limits exposure of the intestine to the active moiety but also sustains systemic concentrations of active drug upon reabsorption of the prodrug. 相似文献
62.
The need to embrace molecular profiling of tumor cells in prostate and bladder cancer. 总被引:2,自引:0,他引:2
Brian J Duggan John J McKnight Kate E Williamson Maurice Loughrey Declan O'Rourke Peter W Hamilton Samuel R Johnston Claude C Schulman Alexandre R Zlotta 《Clinical cancer research》2003,9(4):1240-1247
PURPOSE: Current treatment strategies for urological cancer are still based on empirical formulae as opposed to treatment tailored for each cancer patient. To individualize treatment, the multiple molecular abnormalities within tumor cell populations needs to be mapped out. The aim of this article is to explain molecular profiling (MP) and its associated techniques so that the process is not purely seen as a research tool but as a future adjunctive measure in patient diagnosis and treatment. EXPERIMENTAL DESIGN: A Medline search of publications relating to MP of prostate and bladder cancer was carried out. A review article was written combining the relevant published literature along with the clinical and scientific experience of both centers. RESULTS: The advent of MP now provides a strategy by which these molecular abnormalities can be assessed. As well as being of diagnostic and prognostic use, these molecular profiles will identify putative molecular abnormalities within tumor cells that may be appropriate for therapeutic modulation. CONCLUSIONS: In prostate and bladder cancer, mapping out the molecular abnormalities could be translated into a valuable tool to help solve difficult issues regarding patient management decisions. 相似文献
63.
S. Kennedy M. J. Duffy C. Duggan C. Barnes R. Rafferty M. D. Kramer 《British journal of cancer》1998,77(10):1638-1641
Urokinase plasminogen activator (uPA) is a serine protease involved in cancer invasion and metastasis. uPA acts in vivo by binding to a membrane receptor known as uPAR. In this study, uPA and uPAR levels were semiquantitated by immunocytochemistry in 36 primary breast carcinomas. Using monoclonal antibody HD-UK 1, uPA was detected both in stromal and in malignant cells. However, the predominant location was in the stromal cells. Using double-staining, cells containing uPA were also found to coexpress either cytokeratin (an epithelial cell marker) or more frequently KP1 (a macrophage/monocyte cell marker). With monoclonal antibody HD-uPAR 13.1, uPAR was localized principally to spindle- or macrophage-like stromal cells, especially when these cells surrounded invasive breast cancer. In contrast, uPAR was only rarely detected in cancer cells and was not detected in normal epithelia surrounding tumour or in areas of adenosis. uPA levels in both stromal and epithelial cells were significantly correlated with those for uPAR. We conclude that both uPA and its receptor are mostly present in stromal cells in invasive breast carcinomas. These results suggest that stromal cells collaborate with malignant cells to mediate metastasis. 相似文献
64.
A. G. Remacle A. No??l C. Duggan E. McDermott N. O'Higgins J. M. Foidart M. J. Duffy 《British journal of cancer》1998,77(6):926-931
Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases implicated in cancer invasion and metastasis. Gelatin zymography was performed on 84 human breast carcinomas and seven normal breast tissues. The precursor form of MMP-2 (72 kDa) was found in 11 (12%) samples, while its two activated forms, i.e. 62 kDa and 59 kDa, were found in three (6%) and 34 (40%) samples respectively. In contrast to MMP-2, most of the samples (52%) contained MMP-9 in its precursor form. Using ELISA, MMP-1 levels were found in 12% of the samples while MMP-3 levels were found in only 2% of the samples. Levels of MMP-2, -3 and -9 correlated inversely with numbers of nodal metastases. Neither MMP-2 nor -9 levels were significantly related to patient outcome. However, patients with high levels of a 50-kDa gelatinase band after zymography had a significantly better survival than patients with low levels. This species was never observed in normal breast tissue. 相似文献
65.
Kinta Beaver PhD MRes BA DPSN RGN David Jones MD FRCS † Shabbir Susnerwala MD FRCR ‡ Olive Craven MSc RGN RM Onc.Cert § Mary Tomlinson BA RGN ¶ Gary Witham BA RGN Onc.Cert PG.Cert Karen A Luker PhD BNurs FMedSci †† 《Health expectations》2005,8(2):103-113
OBJECTIVES: To explore patient views on participation in treatment, physical care and psychological care decisions and factors that facilitate and hinder patients from making decisions. DESIGN: Qualitative study using semi-structured interviews with patients. SETTING AND PARTICIPANTS: Three NHS Trusts in the north-west of England. Theoretical sampling including 41 patients who had been treated for colorectal cancer. RESULTS: For patients, participation in the decision-making process was about being informed and feeling involved in the consultation process, whether patients actually made decisions or not. The perceived availability of treatment choices (surgery, radiotherapy, chemotherapy) was related to type of treatment. Factors that impacted on whether patients wanted to make decisions included a lack of information, a lack of medical knowledge and trust in medical expertise. Patients perceived that they could have a more participatory role in decisions related to physical and psychological care. CONCLUSION: This study has implications for health professionals aiming to implement policy guidelines that promote patient participation and shared partnerships. Patients in this study wanted to be well informed and involved in the consultation process but did not necessarily want to use the information they received to make decisions. The presentation of choices and preferences for participation may be context specific and it cannot be assumed that patients who do not want to make decisions about one aspect of their care and treatment do not want to make decisions about other aspects of their care and treatment. 相似文献
66.
67.
Miranda Leontowitsch Fiona Stevenson Irwin Nazareth Catherine Duggan 《The International journal of pharmacy practice》2005,13(4):273-280
Objectives To assess the feasibility and acceptability of concordance in pharmacy practice through examination of communication between customers and pharmacists in two community pharmacies in consultations for over‐the‐counter medicines. Method A qualitative pilot study involving data drawn from six sources: audiotaped training session with all the pharmacists involved, observational field work in the pharmacies, audiotaped consultations with pharmacists and customers, debriefing interviews with pharmacists after the consultation, and semi‐structured interviews with customers a few days after their consultation. Setting Two community pharmacies that concentrate their services on medicine advice and dispensing, one in a deprived inner‐city area, the other in a more affluent suburban area of London. Key findings The pharmacists developed a personal understanding of concordance which informed their practice. Customers reported a high level of satisfaction with services they received from the respective pharmacists. Their accounts of the consultations verified the pharmacists' patient‐centredness in their day‐to‐day practice. Conclusion The implementation of a concordance model was possible through the development of a personalised, patient‐centred model which drew on the model of concordance but was adapted in accordance with both structural constraints as well as the personal style of the pharmacists involved. 相似文献
68.
Kevin X. Liu Eileen M. Duggan Alyaa Al‐Ibraheemi Raja Shaikh Denise M. Adams 《Pediatric blood & cancer》2019,66(1)
Epithelioid hemangioma (EH) is a rare benign vascular tumor that occurs in soft tissues and bone and presents between the third and sixth decades of life. Little is known about the clinical course and outcomes of pediatric EH. We report 11 patients diagnosed with EH at a median age of 14.4 years. One patient treated with interferon and one with sirolimus exhibited partial response for >2 years. Although a benign neoplasm, EH is difficult to manage without standard protocols and portends considerable morbidity. Our findings suggest medical management, particularly sirolimus, may benefit these patients; however, long‐term follow‐up is needed. 相似文献
69.
70.
Using action research to develop midwives’ skills to support women with perinatal mental health needs 下载免费PDF全文